Asthma is a chronic respiratory condition characterized by bronchial hyper-responsiveness
secondary to abnormal inflammation of the lung. Steroids remain the most effective treatment
for this condition. The lipid lowering agents statins have been found to have
anti-inflammatory properties. This study is to test the hypothesize that statins will
decrease bronchial hyperresponsiveness and inflammation, leading to improved symptoms in
patients with asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Queen's University
Collaborators:
Ontario Lung Association The Physicians' Services Incorporated Foundation